Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients.

OBJECTIVE: The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non-ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.

METHODS: 300 NSTE-ACS patients were enrolled in the study. SVEAT scores were calculated in an emergency room. After coronary angiography was performed for each patient, SYNTAX scores were calculated and the results compared.

RESULTS: The total population was 300 patients, with a mean age of 60.35 ± 12.07, 68.7% of whom were of the male sex (n = 206). The median SYNTAX score of the study group was 8.00 (3.00-16.00). SVEAT scores showed a profound positive correlation with SYNTAX scores (r = 0.702, p < 0.001). An SVEAT score ≥ 5 predicted higher SYNTAX scores with 83% specificity and 73% sensitivity. Lower ejection fraction (r = -0.355, p < 0.001) and lower high-density lipoprotein (r = -0.174, p = 0.004) were linked to higher SYNTAX scores.

CONCLUSION: This study is a first for the presentation of the SVEAT score as a reliable tool for estimating the SYNTAX score in NSTE-ACS patients. It will provide valuable insight to clinicians for risk stratification.